Login to Your Account



Other News To Note


Tuesday, January 17, 2012
• Seattle Genetics Inc., of Bothell, Wash., updated its prescribing information for Adcetris (brentuximab vedotin) to include a boxed warning regarding JC virus infection leading to progressive multifocal leudoencephalopathy and death.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription